Single-step extraction of fluconazole from plasma by ultra-filtration for the measurement of its free concentration by high performance liquid chromatography

被引:38
作者
Majcherczyk, PA [1 ]
Moreillon, P
Decosterd, LA
Sanglard, D
Bille, J
Glauser, MP
Marchetti, O
机构
[1] CHU Vaudois, Div Infect Dis, Dept Internal Med, CH-1011 Lausanne, Switzerland
[2] CHU Vaudois, Div Clin Pharmacol, Dept Internal Med, CH-1011 Lausanne, Switzerland
[3] CHU Vaudois, Inst Microbiol, CH-1011 Lausanne, Switzerland
关键词
plasma ultra-filtration; single-step extraction; fluconazole; HPLC;
D O I
10.1016/S0731-7085(01)00686-0
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
High performance liquid chromatography (HPLC) is the reference method for measuring concentrations of antimicrobials in blood. This technique requires careful sample preparation. Protocols using organic solvents and/or solid extraction phases are time consuming and entail several manipulations, which can lead to partial loss of the determined compound and increased analytical variability. Moreover, to obtain sufficient material for analysis, at least 1 ml of plasma is required. This constraint makes it difficult to determine drug levels when blood sample volumes are limited. However, drugs with low plasma-protein binding can be reliably extracted from plasma by ultra-filtration with a minimal loss due to the protein-bound fraction. This study validated a single-step ultra-filtration method for extracting fluconazole (FLC), a first-line antifungal agent with a weak plasma-protein binding, from plasma to determine its concentration by HPLC. Spiked FLC standards and unknowns were prepared in human and rat plasma. Samples (240 1) were transferred into disposable microtube filtration units containing cellulose or polysulfone filters with a 5 kDa cut-off. After centrifugation for 60 min at 15000g, FLC concentrations were measured by direct injection of the filtrate into the HPLC. Using cellulose filters, low molecular weight proteins were eluted early in the chromatogram and well separated from FLC that eluted at 8.40 min as a sharp single peak. In contrast, with polysulfone filters several additional peaks interfering with the FLC peak were observed. Moreover, the FLC recovery using cellulose filters compared to polysulfone filters was higher and had a better reproducibility. Cellulose filters were therefore used for the subsequent validation procedure. The quantification limit was 0.195 mg 1(-1). Standard curves with a quadratic regression coefficient greater than or equal to 0.9999 were obtained in the concentration range of 0.195 - 100 mg 1(-1). The inter and intra-run accuracies and precisions over the clinically relevant concentration range, 1.875-60 mg 1(-1), fell well within the +/-15% variation recommended by the current guidelines for the validation of analytical methods. Furthermore, no analytical interference was observed with commonly used antibiotics, antifungals, antivirals and immuno suppressive agents. Ultra-filtration of plasma with cellulose filters permits the extraction of FLC from small volumes (240 mul). The determination of FLC concentrations by HPLC after this single-step procedure is selective, precise and accurate. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:645 / 651
页数:7
相关论文
共 12 条
[1]   Determination of cefepime and cefpirome in human serum by high-performance liquid chromatography using an ultrafiltration for antibiotics serum extraction [J].
Breilh, D ;
Lavallee, C ;
Fratta, A ;
Ducint, D ;
Cony-Makhoul, P ;
Saux, MC .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1999, 734 (01) :121-127
[2]   Determination of imipenem in plasma by high-performance liquid chromatography for pharmacokinetic studies in patients [J].
GarciaCapdevila, L ;
LopezCalull, C ;
Arroyo, C ;
Moral, MA ;
Mangues, MA ;
Bonal, J .
JOURNAL OF CHROMATOGRAPHY B, 1997, 692 (01) :127-132
[3]   FLUCONAZOLE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN SUPERFICIAL AND SYSTEMIC MYCOSES [J].
GRANT, SM ;
CLISSOLD, SP .
DRUGS, 1990, 39 (06) :877-916
[4]  
Hulsewede JW, 1996, ZBL BAKT-INT J MED M, V283, P492
[5]   DETERMINATION OF FLUCONAZOLE IN HUMAN SERUM BY SOLID-PHASE EXTRACTION AND REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
INAGAKI, K ;
TAKAGI, J ;
LOR, E ;
OKAMOTO, MP ;
GILL, MA .
THERAPEUTIC DRUG MONITORING, 1992, 14 (04) :306-311
[6]   Simultaneous determination of zidovudine and lamivudine in human serum using HPLC with tandem mass spectrometry [J].
Kenney, KB ;
Wring, SA ;
Carr, RM ;
Wells, GN ;
Dunn, JA .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 22 (06) :967-983
[7]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF THE ANTIFUNGAL DRUG FLUCONAZOLE IN PLASMA AND SALIVA OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS [J].
KOKS, CHW ;
ROSING, H ;
MEENHORST, PL ;
BULT, A ;
BEIJNEN, JH .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 663 (02) :345-351
[8]   Sensitive bioassay for determination of fluconazole concentrations in plasma using a Candida albicans mutant hypersusceptible to azoles [J].
Marchetti, O ;
Majcherczyk, PA ;
Glauser, MP ;
Bille, J ;
Moreillon, P ;
Sanglard, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) :696-700
[9]  
NISHIHIMA MK, 1990, J CHROMATOGR B, V529, P223
[10]   STANDARDIZATION OF A FLUCONAZOLE BIOASSAY AND CORRELATION OF RESULTS WITH THOSE OBTAINED BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY [J].
REX, JH ;
HANSON, LH ;
AMANTEA, MA ;
STEVENS, DA ;
BENNETT, JE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (05) :846-850